首页> 外文期刊>Asian Pacific Journal of Cancer Prevention >Long-term Efficacy of Microwave Hyperthermia Combined with Chemoradiotherapy in Treatment of Nasopharyngeal Carcinoma with Cervical Lymph Node Metastases
【24h】

Long-term Efficacy of Microwave Hyperthermia Combined with Chemoradiotherapy in Treatment of Nasopharyngeal Carcinoma with Cervical Lymph Node Metastases

机译:微波热疗的长期疗效与颈淋巴结转移治疗鼻咽癌治疗鼻咽癌

获取原文
           

摘要

Objective: The long-term efficacy of microwave hyperthermia combined with chemoradiotherapy in treating nasopharyngeal carcinoma (NPC) with metastatic foci in cervical lymph nodes was evaluated. Methods: A total of 154 cases of N2 or N3 stage NPC were randomized into two groups: hyperthermia group (76 cases) and control group (78 cases). Both received cisplatin chemotherapy and radiotherapy. In addition, the hyperthermia group further received microwave hyperthermia to the metastatic cervical nodes with different patterns (before or after radiotherapy), heating temperatures (T90 and ) and hyperthermia episodes ( 10 times). Results: The 3-month and 5-year complete response (CR) rates of cervical lymph nodes in the hyperthermia group were significantly higher than those in the control group. The 5-year disease-free survival (DFS) rate and the 3-year / 5-year overall survival rate in the hyperthermia group were also significantly higher. There was no significant difference in 5-year metastatic rates. In the hyperthermia group, the 3-month and 5-year CR rates of T90 treatment were significantly lower than with treatment. The CR rate was highest when the hyperthermia was performed 4-10 times. There were no significant differences in 3-month and 5-year CR rates between hyperthermia before or after radiotherapy treatment. Conclusion: Microwave hyperthermia combined with chemoradiotherapy can increase local control, DFS and 3, 5-year overall survival rates of patients with N2 ~ N3 stage NPC. The heating temperature should be over with hyperthermia repeated 4-10 times.
机译:目的:评价微波热疗结合化学疗法治疗颈椎淋巴结转移灶治疗鼻咽癌(NPC)的长期疗效。方法:总共154例N2或N3阶段NPC随机分为两组:热疗组(76例)和对照组(78例)。都接受了顺铂化疗和放射疗法。此外,热疗组进一步接受微波热疗到具有不同模式(放射治疗之前或之后)的转移性宫颈节点,加热温度(T90和)和热疗发作(10次)。结果:高温菌群中颈淋巴结的3个月和5年的完整响应(CR)率明显高于对照组中的响应率。 5年的疾病生存(DFS)率和高温菌群中的3年/ 5年总生存率也明显高。 5年的转移率没有显着差异。在热疗组中,3个月和5年的T90治疗的CR率明显低于治疗。当热疗进行4-10次时,Cr率最高。在放疗治疗之前或之后的高温血症之间的3个月和5年CR率没有显着差异。结论:微波热疗结合化学疗法可增加局部对照,DFS和3,5年的N2〜N3阶段NPC患者的总生存率。热温应在热疗中重复4-10次加热温度。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号